Although ctDNA positivity generally meant worse disease-free survival in stage 3 resected colon cancer, patients with ctDNA ...

The results could sway U.S. regulators to convert Braftovi’s accelerated clearance in colorectal tumors into a full approval ...

Colonic lipomas are benign tumors composed of adipose (fat) tissue that can occur in the gastrointestinal tract, particularly in the colon. While often asymptomatic, these tumors can lead to ...

New data from two studies presented at ASCO GI 2025 demonstrated that ctDNA testing could predict recurrence risk in ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients found that patients with evidence of residual cancer in their blood after surgery to remove the cancer, may benefit ...

Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...

The Alliance for Clinical Trials in Oncology today announced the results of a data analysis from a randomized phase III ...

A study finds that celecoxib improves disease-free survival in stage 3 colon cancer patients with positive ctDNA after ...

Recent research indicates that colon cancer patients with circulating tumor DNA post-surgery may improve their survival likelihood with daily celecoxib use. Celecoxib, a COX-2 inhibitor, significantly ...

The Alliance for Clinical Trials in Oncology today announced the results of a data analysis from a randomized phase III clinical trial involving patients with stage III colon cancer, which found that ...

Colorectal cancer is the second leading cause of cancer death in the U.S., with over 152,000 cases and nearly 53,000 deaths estimated in 2024. Morning ...